| Authors: |
Saleh K; Department of Head and Neck Oncology, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: khalil_saleh@live.com., Auperin A; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Villejuif, France., Martin N; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Borcoman E; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France., Torossian N; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France., Iacob M; Department of Head and Neck Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Ferrand FR; Department of Head and Neck Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Khalife N; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Baste N; Department of Head and Neck Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Guigay J; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Le Tourneau C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France; INSERM U900 Research Unit, Saint-Cloud, France; Paris-Saclay University, Paris, France., Daste A; Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital-CHU Bordeaux, France., Saada-Bouzid E; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France; Université Côte d'Azur, Nice, France., Even C; Department of Head and Neck Oncology, Gustave Roussy Cancer Campus, Villejuif, France. |
